Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Knight Therapeutics Inc
T.GUD
Alternate Symbol(s):
KHTRF
Healthcare
Biotechnology
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select...
international markets. The Company monitors investments in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by the Company such as Exelon and Impavido.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (TSX:GUD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(5)
•••
3Briers
X
Comment by
3Briers
on Nov 06, 2025 10:16am
RE:How to loose a billion dollar and not make a cent profit
Receivables at 171 on quarterly sales of 121 MMM collection is over 120 days WTF
(3)
•••
Chianchin
X
Post by
Chianchin
on Nov 05, 2025 8:26pm
How to loose a billion dollar and not make a cent profit
I have just dropped by to see how many of tose who lost fortunes are still here hoping. GUD 10 years ago had about a billion dollar in cash, it did not make a cent profits and now is borrowing money
...more
(25)
•••
longrun86
X
Comment by
longrun86
on Nov 01, 2025 3:56pm
RE:Is this the buy time?
If I read the press release correctly, the credit facility size can go as high as $200 million USD. That is a positive development to the extent that Management sees an opportunity to make profitable
...more
(31)
•••
Tulsa123
X
Post by
Tulsa123
on Nov 01, 2025 10:06am
Is this the buy time?
New products, insider interest,Banks faith.what's your opinion?
(1)
•••
GoldenInvestor
X
Post by
GoldenInvestor
on Sep 30, 2025 3:56pm
Successive days over 100 k shares
Lots of days stringing together as looks like people building new bases. thoughts?
(1650)
•••
Possibleidiot01
X
Post by
Possibleidiot01
on Sep 16, 2025 3:16pm
Andrey Omelchak
PAST TOP PICK Knight Therapeutics(GUD-T) Sep 16, 2025 (A Top Pick Sep 10/24, Up 5%) Shares are flat, but the company has done well the past 12 months
...more
(6)
•••
curiousj
X
Comment by
curiousj
on Aug 26, 2025 8:02am
RE:RE:New NCIB
seen this with another company, seems that standard maximum purchases on TSX stock market are for 10% of float
(25)
•••
longrun86
X
Comment by
longrun86
on Aug 23, 2025 11:22pm
RE:The Next Few Years (EBITDA Margin)
This is certainly why I have been sticking around watching the paint dry! I feel like Knight is the type of business where you can get a virtuous cycle going. They should be getting close now. LR
(14)
•••
gudisgood
X
Comment by
gudisgood
on Aug 23, 2025 3:58pm
RE:New NCIB
I'm not sure what to make of the wording but I'm actually surprised that they would continue the buybacks. Happily surprised, that is! I expected them not to continue since they've
...more
(14)
•••
gudisgood
X
Post by
gudisgood
on Aug 23, 2025 6:19am
The Next Few Years (EBITDA Margin)
Even with this relatively quiet forum area, I'm surprised nobody has mentioned the EBITDA margin roadmap Samira essentially laid out in the latest earnings call: "We'll guide to 2026
...more
(7)
•••
EbbFlow88
X
Post by
EbbFlow88
on Aug 20, 2025 8:56am
New NCIB
Knight announced the new NCIB from a year ago. About a month after their usual renewal date. The wording has changed slightly which I found interesting. It seems the float has decreased meaning there
...more
(179)
•••
Catscratch
X
Comment by
Catscratch
on Jul 31, 2025 9:24pm
RE:No longer a NAV Based Valuation
When a value stock becomes a growth stock excellent returns can be realized. It takes significant discipline and patience to hold through this transition.
(25)
•••
longrun86
X
Post by
longrun86
on Jul 17, 2025 5:20pm
No longer a NAV Based Valuation
Hi Folks, For the last several years the only real way to value Knight has been a "sum of parts" valuation and to hope that one day they would hit enough critical mass to be valued using an
...more
(1)
•••
GoldenInvestor
X
Post by
GoldenInvestor
on Jun 10, 2025 3:48pm
Incidence rates of 2 of new products - wow!
2024 - adult male Canadians to be diagnosed with prostate cancer was 27,900 in 2024 5000 Canadian men were projected to die from prostate cancer Huge opportunity for Orgovyx to help, from new
...more
(6)
•••
curiousj
X
Post by
curiousj
on May 15, 2025 8:58am
any thoughts GPM gap and Argentina business
How are you thinking about the widening gap between IFRS GPM and adj GPM at 7% highest its been while inflation has slowed in Argentina? Any general thoughts on branded generics business...
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
Pinnacle Extends Gold-Silver Mineralized Horizon to Almost 500 Metres at Historic La Dura Mine
SALT: quietly powering industries, keeping roads safe, and even shaping the global economy
The first public copper company permitted to drill in Argentina’s newly opened Mendoza province
Eshbal Signs Definitive Agreement to Acquire Majority Interest in NYC-Based Dare to Be Different Foods
Allied Critical Metals Confirms Ultra High-Grade Tungsten Zone at Borralha